{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:43:48Z","timestamp":1778715828248,"version":"3.51.4"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T00:00:00Z","timestamp":1655683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Proliferative vasculopathy (PV) associated antiphospholipid syndrome (APS) in the central nervous system is a rare un(der)recognized form of extra-criteria manifestations of APS. This study investigated the angiographic characteristics of cerebral and cervical arteries in patients with PV associated with antiphospholipid antibodies (aPLs).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients with aPLs, neurologic symptoms and diffuse luminal narrowing on brain or neck magnetic resonance angiography were selected from electronic medical records. Vascular wall and intraluminal pathology were examined by high-resolution vessel wall MR imaging (VW-MRI).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 11 patients (six men and five women) with PV-aPL, of median (interquartile range) age 42 (34\u201361) years, were included. Median anticardiolipin antibodies IgG titer was 78.9 (28.2\u2013134.0) units and anti-beta 2 glycoprotein I antibodies (aB2GPIs) IgG titer was 227.2 (0.0\u20131012.1) units. All patients had diffuse luminal narrowing in the carotid basilar and\/or cerebral arteries, five in the internal carotid artery (ICA); two each in the middle cerebral artery (MCA) and vertebral artery; and one each in the basilar artery (BA) and posterior cerebral artery. On VW-MRI, four patients showed concentric thickening of the vascular walls of the ICA and\/or MCA and two showed mild eccentric wall thickening of the ICA or BA. All patients received antithrombotic treatment. In two patients with extremely high aB2GPIs titer, diffuse narrowing progressed despite treatment with antithrombotic agents on follow-up imaging.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study suggests that PV-aPL might be a distinct extra-criteria manifestation of APS that can manifest as long-segmental diffuse stenosis of cerebral and cervical arteries. It should be considered in relatively young patients with neurologic symptoms and aPLs.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.913203","type":"journal-article","created":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T12:48:47Z","timestamp":1655729327000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Proliferative Vasculopathy Associated With Antiphospholipid Antibodies in Patients With Neurological Symptoms"],"prefix":"10.3389","volume":"9","author":[{"given":"Jina","family":"Yeo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inpyeong","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chul-Ho","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunyoung Emily","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soon-Tae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Bong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Kyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199907)42:7&lt;1309::AID-ANR1&gt;3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMra1112830","article-title":"The pathogenesis of the antiphospholipid syndrome","volume":"368","author":"Giannakopoulos","year":"2013","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/rheumatology\/keg080","article-title":"Central nervous system involvement in the antiphospholipid (Hughes) syndrome","volume":"42","author":"Sanna","year":"2003","journal-title":"Rheumatology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1161\/01.STR.32.8.1701","article-title":"beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the honolulu heart program","volume":"32","author":"Brey","year":"2001","journal-title":"Stroke."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mmr.2020.11787","article-title":"OxLDL\/beta2GPI\/antibeta2GPI Ab complex induces inflammatory activation via the TLR4\/NFkappaB pathway in HUVECs","volume":"23","author":"Zhang","year":"2021","journal-title":"Mol Med Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1053\/j.ajkd.2019.08.032","article-title":"mTORC Pathway activation and effect of sirolimus on native kidney antiphospholipid syndrome nephropathy: a case report","volume":"76","author":"Dufour","year":"2020","journal-title":"Am J Kidney Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3389\/fimmu.2018.00969","article-title":"Cellular and molecular mechanisms of anti-phospholipid syndrome","volume":"9","author":"Radic","year":"2018","journal-title":"Front Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1080\/14397595.2016.1218596","article-title":"Nonthrombotic proliferative vasculopathy associated with antiphospholipid antibodies: a case report and literature review","volume":"29","author":"Lee","year":"2019","journal-title":"Mod Rheumatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1002\/art.1780350908","article-title":"Neuropathologic findings in multi-infarct dementia associated with anticardiolipin antibody. Evidence for endothelial injury as the primary event","volume":"35","author":"Westerman","year":"1992","journal-title":"Arthritis Rheum."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1056\/NEJMra1705454","article-title":"Diagnosis and management of the antiphospholipid syndrome","volume":"378","author":"Garcia","year":"2018","journal-title":"N Engl J Med."},{"key":"B11","first-page":"611","article-title":"Antiphospholipid antibodies: findings at arteriography","volume":"19","author":"Provenzale","year":"1998","journal-title":"AJNR Am J Neuroradiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1055\/s-0038-1649901","article-title":"Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the subcommittee on lupus anticoagulant\/antiphospholipid antibody of the scientific and standardisation committee of the ISTH","volume":"74","author":"Brandt","year":"1995","journal-title":"Thromb Haemost."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann Rheum Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3171\/jns.1981.54.2.0151","article-title":"Microsurgical anatomy of the middle cerebral artery","volume":"54","author":"Gibo","year":"1981","journal-title":"J Neurosurg."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.3389\/fneur.2018.01001","article-title":"antiphospholipid syndrome and the neurologist: from pathogenesis to therapy","volume":"9","author":"Fleetwood","year":"2018","journal-title":"Front Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"18005","DOI":"10.1038\/nrdp.2017.103","article-title":"Antiphospholipid syndrome","volume":"4","author":"Schreiber","year":"2018","journal-title":"Nat Rev Dis Primers."},{"key":"B18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.rdc.2006.05.010","article-title":"Cerebral manifestations in the antiphospholipid (Hughes) syndrome","volume":"32","author":"Sanna","year":"2006","journal-title":"Rheum Dis Clin North Am."},{"key":"B19","doi-asserted-by":"publisher","first-page":"239398","DOI":"10.1155\/2014\/239398","article-title":"Revisiting the molecular mechanism of neurological manifestations in antiphospholipid syndrome: beyond vascular damage","volume":"2014","author":"Carecchio","year":"2014","journal-title":"J Immunol Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1191\/0961203305lu2176oa","article-title":"The impact of gender on clinical manifestations of primary antiphospholipid syndrome","volume":"14","author":"Jara","year":"2005","journal-title":"Lupus."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients","volume":"74","author":"Cervera","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1136\/ard.2004.034231","article-title":"Prevalence of the antiphospholipid syndrome in primary systemic vasculitis","volume":"65","author":"Rees","year":"2006","journal-title":"Ann Rheum Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.3174\/ajnr.A2697","article-title":"angiography and imaging for the evaluation of middle cerebral artery atherosclerotic disease","volume":"33","author":"Degnan","year":"2012","journal-title":"AJNR Am J Neuroradiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0002-9343(76)90431-9","article-title":"The bimodal mortality pattern of systemic lupus erythematosus","volume":"60","author":"Urowitz","year":"1976","journal-title":"Am J Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/0002-8703(85)90023-7","article-title":"Cardiovascular manifestations of systemic lupus erythematosus","volume":"110","author":"Doherty","year":"1985","journal-title":"Am Heart J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.semarthrit.2017.10.015","article-title":"Carotid and femoral atherosclerosis in antiphospholipid syndrome: equivalent risk with diabetes mellitus in a case-control study","volume":"47","author":"Kravvariti","year":"2018","journal-title":"Semin Arthritis Rheum."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1016\/S0140-6736(18)31327-8","article-title":"Antiphospholipid syndrome causing reversible internal carotid artery thrombosis","volume":"391","author":"Xiao","year":"2018","journal-title":"Lancet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.3174\/ajnr.A3909","article-title":"High-resolution MRI vessel wall imaging: spatial and temporal patterns of reversible cerebral vasoconstriction syndrome and central nervous system vasculitis","volume":"35","author":"Obusez","year":"2014","journal-title":"AJNR Am J Neuroradiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1191\/0961203302lu165oa","article-title":"Anticardiolipin antibody titre and plasma homocysteine level independently predict intima media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies","volume":"11","author":"Ames","year":"2002","journal-title":"Lupus."},{"key":"B30","doi-asserted-by":"publisher","first-page":"108172","DOI":"10.1016\/j.pharmthera.2022.108172","article-title":"Reducing residual cardiovascular risk in Europe: Therapeutic implications of European medicines agency approval of icosapent ethyl\/eicosapentaenoic acid","volume":"237","author":"Chapman","year":"2022","journal-title":"Pharmacol Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1177\/0961203314540761","article-title":"Moyamoya syndrome with antiphospholipid antibodies: a case report and literature review","volume":"23","author":"Wang","year":"2014","journal-title":"Lupus."},{"key":"B32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000028830","article-title":"Primary antiphospholipid syndrome with moyamoya-like vascular changes","volume":"31","author":"Booth","year":"1999","journal-title":"Pediatr Neurosurg."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1161\/STROKEAHA.114.005618","article-title":"Vessel wall magnetic resonance imaging in acute ischemic stroke: effects of embolism and mechanical thrombectomy on the arterial wall","volume":"45","author":"Power","year":"2014","journal-title":"Stroke."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3840","DOI":"10.1007\/s00330-018-5323-4","article-title":"Three-dimensional black-blood contrast-enhanced MRI improves detection of intraluminal thrombi in patients with acute ischaemic stroke","volume":"28","author":"Jang","year":"2018","journal-title":"Eur Radiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"817","DOI":"10.17179\/excli2020-1512","article-title":"Pathophysiology and therapy of systemic vasculitides","volume":"19","author":"Ralli","year":"2020","journal-title":"EXCLI J."},{"key":"B36","first-page":"762","article-title":"Antiphospholipid arterial vasculopathy","volume":"16","author":"Alarcon-Segovia","year":"1989","journal-title":"J Rheumatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMp038124","article-title":"Cardiac-allograft vasculopathy","volume":"349","author":"Avery","year":"2003","journal-title":"N Engl J Med."},{"key":"B38","first-page":"S19","article-title":"Vascular involvement in systemic sclerosis (SSc)","volume":"22","author":"Kahaleh","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1111\/j.1538-7836.2007.02680.x","article-title":"Role of p38 mitogen-activated protein kinase in antiphospholipid antibody-mediated thrombosis and endothelial cell activation","volume":"5","author":"Vega-Ostertag","year":"2007","journal-title":"J Thromb Haemost."},{"key":"B40","first-page":"850","article-title":"Relationship between cerebrovascular and valvular manifestations in a Serbian cohort of patients with antiphospholipid syndrome","volume":"36","author":"Djokovic","year":"2018","journal-title":"Clin Exp Rheumatol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.913203\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T12:48:52Z","timestamp":1655729332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.913203\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,20]]},"references-count":40,"alternative-id":["10.3389\/fmed.2022.913203"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.913203","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,20]]},"article-number":"913203"}}